Myxoma natural history

Jump to navigation Jump to search

Myxoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myxoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myxoma natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myxoma natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myxoma natural history

CDC on Myxoma natural history

Myxoma natural history in the news

Blogs on Myxoma natural history

Directions to Hospitals Treating Myxoma

Risk calculators and risk factors for Myxoma natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]Maria Fernanda Villarreal, M.D. [3]

Overview

Cardiac myxoma progression occurs slowly, the overlapping of various phenomena such as thrombosis, hemorrhage, or fragmentation may influence tumor growth, detachment, and consequently embolism. Complications that can develop as a result of myxoma are: arrhythmias, pulmonary edema, peripheral emboli, metastasis, blockage of the mitral heart valve. The survival rates after 5-years are 83% for benign heart tumors.[1]

Natural History

If left untreated, cardiac myxoma progression occurs slowly. The overlapping of various phenomena such as thrombosis, hemorrhage, or fragmentation may influence tumor growth, detachment and consequently embolism.[2] Constitutional symptoms, such as: weight loss, fatigue, weakness are often the initial clinical onset of cardiac myxoma, and may resemble those from endocarditis. Metastases are very uncommon in cardiac myxoma.

Since the majority of the cardiac myxomas are left sided, it may progress to develop mitral valve obstruction or systemic embolic events, such as cerebral stroke. Whereas, right atrial myxomas may obstruct the tricuspid valve and can present as right sided heart failure. Approximately 20% of patients with cardiac myxoma are asymptomatic. Overall, clinical features of cardiac myxoma are associated with the size of the tumor, location, size and mobility.[3]

Complications

Complications are common. Some of the complications that may develop as a result of myxoma are:[4]

Prognosis

Depending on the complications derivated from the cardiac myxoma at the time of diagnosis (embolic event or valve obstruction) the prognosis may vary. However with no complications, the prognosis is generally regarded as favorable after surgery. Recurrence rates (either locally or elsewhere in the heart) reported in 1-3% of cases. In atypical cases the rate is much higher (12-22%)[5] . The survival rates after 5-years are 83% for benign heart tumors.[1]

References

  1. 1.0 1.1 Hoffmeier A, Sindermann JR, Scheld HH, Martens S (2014). "Cardiac tumors--diagnosis and surgical treatment". Dtsch Arztebl Int. 111 (12): 205–11. doi:10.3238/arztebl.2014.0205. PMC 3983698. PMID 24717305.
  2. Markel ML, Waller BF, Armstrong WF (1987). "Cardiac myxoma. A review". Medicine (Baltimore). 66 (2): 114–25. PMID 3547010.
  3. Burke A, Virmani R. Tumors of the Heart and Great Vessels. Amer Registry of Pathology; 1996.
  4. Atrial myxoma. Wikipedia https://en.wikipedia.org/wiki/Atrial_myxoma Accessed November 13, 2015
  5. Prognosis-Cardiac Myxoma.Radiopedia http://radiopaedia.org/articles/cardiac-myxoma Accessed on November 13,2015


Template:WikiDoc Sources